NFKB1 and metabolic dysfunction-associated steatohepatitis: TLR4 signaling pathway: Previous studies have demonstrated that TLR4 affects critical signaling pathways such as inflammation, IR, and metabolic balance, principally through the regulation of IKK/NF-κB and MAPK, which govern NASH (87, 88).